Please use this identifier to cite or link to this item:
Title: The effect of polyethylene glycol structure on paclitaxel drug release and mechanical properties of PLGA thin films
Authors: Steele, Terry W. J.
Huang, Charlotte L.
Widjaja, Effendi
Boey, Freddy Y. C.
Loo, Joachim Say Chye
Venkatraman, Subbu S.
Keywords: Raman spectra
Issue Date: 2011
Source: Steele, T. W. J., Huang, C. L., Widjaja, E., Boey, F. Y. C., Loo, J. S. C., & Venkatraman, S. S. (2011). The effect of polyethylene glycol structure on paclitaxel drug release and mechanical properties of PLGA thin films. Acta Biomaterialia, 7(5), 1973-1983.
Series/Report no.: Acta Biomaterialia
Abstract: Thin films of poly(lactic acid-co-glycolic acid) (PLGA) incorporating paclitaxel typically have slow release rates of paclitaxel of the order of 1 μg day−1 cm−2. For implementation as medical devices a range of zero order release rates (i.e. 1–15 μg day−1 cm−2) is desirable for different tissues and pathologies. Eight and 35 kDa molecular weight polyethylene glycol (PEG) was incorporated at 15%, 25% and 50% weight ratios into PLGA containing 10 wt.% paclitaxel. The mechanical properties were assessed for potential use as medical implants and the rates of release of paclitaxel were quantified as per cent release and the more clinically useful rate of release in μg day−1 cm−2. Paclitaxel quantitation was correlated with the release of PEG from PLGA, to further understand its role in paclitaxel/PLGA release modulation. PEG release was found to correlate with paclitaxel release and the level of crystallinity of the PEG in the PLGA film, as measured by Raman spectrometry. This supports the concept of using a phase separating, partitioning compound to increase the release rates of hydrophobic drugs such as paclitaxel from PLGA films, where paclitaxel is normally homogeneously distributed/dissolved. Two formulations are promising for medical device thin films, when optimized for tensile strength, elongation, and drug release. For slow rates of paclitaxel release an average of 3.8 μg day−1 cm−2 using 15% 35k PEG for >30 days was achieved, while a high rate of drug release of 12 μg day−1 cm−2 was maintained using 25% 8 kDa PEG for up to 12 days.
ISSN: 1742-7061
DOI: 10.1016/j.actbio.2011.02.002
Rights: © 2011 Acta Materialia Inc. (published by Elsevier Ltd.). This is the author created version of a work that has been peer reviewed and accepted for publication in Acta Biomaterialia, published by Elsevier Ltd. on behalf of Acta Materialia Inc.. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [].
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:MSE Journal Articles

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.